These results to a large extent suggest that SLC35A2 may also regulate the metabolic activities of other cells in the tumor microenvironment, including immune cells and endothelial cells as is closely related to the metabolism of cancer cells, so as to promote the proliferation and angiogenesis of cancer cells. This evidence concerns the gene SLC35A2 and neoplasm.